Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abemaciclib and Pembrolizumab in Advanced Gastroesophageal Adenocarcinoma
NCT03997448Phase 2Terminated
- Start
- Aug 2019
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of abemaciclib in gastroesophageal adenocarcinoma. Started Aug 2019; status: terminated.
02
Drugs
abemaciclib
03
Conditions
gastroesophageal adenocarcinoma
Beyond the preview
Go deeper on NCT03997448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03997448.